Net profit of Novartis India rose 99.59% to Rs 29.30 crore in the quarter ended March 2025 as against Rs 14.68 crore during the previous quarter ended March 2024. Sales rose 3.34% to Rs 83.88 crore in the quarter ended March 2025 as against Rs 81.17 crore during the previous quarter ended March 2024.
For the full year,net profit rose 18.44% to Rs 100.90 crore in the year ended March 2025 as against Rs 85.19 crore during the previous year ended March 2024. Sales rose 6.33% to Rs 356.27 crore in the year ended March 2025 as against Rs 335.07 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 83.88 | 81.17 | 3 | 356.27 | 335.07 | 6 |
| OPM % | 28.51 | 13.81 | - | 25.66 | 19.48 | - |
| PBDT | 34.42 | 21.47 | 60 | 132.61 | 125.45 | 6 |
| PBT | 33.89 | 21.33 | 59 | 130.42 | 122.84 | 6 |
| NP | 29.30 | 14.68 | 100 | 100.90 | 85.19 | 18 |